| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
21,461 |
20,011 |
$3.90M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,564 |
17,855 |
$2.17M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,563 |
12,663 |
$1.94M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,058 |
1,994 |
$350K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,665 |
8,300 |
$221K |
| 80053 |
Comprehensive metabolic panel |
24,026 |
23,089 |
$210K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
683 |
677 |
$128K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,968 |
25,783 |
$125K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,400 |
1,342 |
$89K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,816 |
6,498 |
$88K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,092 |
3,873 |
$72K |
| 84702 |
|
5,077 |
4,862 |
$70K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,181 |
1,146 |
$67K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,606 |
7,289 |
$66K |
| 70450 |
Computed tomography, head or brain; without contrast material |
951 |
924 |
$60K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
318 |
314 |
$58K |
| 36415 |
Collection of venous blood by venipuncture |
17,579 |
16,165 |
$54K |
| 71045 |
Radiologic examination, chest; single view |
6,562 |
6,371 |
$50K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
885 |
814 |
$49K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
860 |
802 |
$48K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,245 |
4,014 |
$36K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
433 |
418 |
$33K |
| 84484 |
|
3,864 |
3,615 |
$32K |
| 81001 |
|
13,439 |
12,937 |
$32K |
| 83690 |
|
7,116 |
6,856 |
$29K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
272 |
261 |
$22K |
| G0378 |
Hospital observation service, per hour |
51 |
51 |
$21K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
570 |
527 |
$18K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
602 |
571 |
$16K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
230 |
224 |
$15K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
253 |
240 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,039 |
1,962 |
$13K |
| 76830 |
Ultrasound, transvaginal |
246 |
232 |
$11K |
| 80050 |
General health panel |
211 |
202 |
$9K |
| 93971 |
|
161 |
155 |
$9K |
| 87040 |
|
437 |
413 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
594 |
537 |
$7K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
212 |
198 |
$7K |
| 76801 |
|
164 |
154 |
$6K |
| 85730 |
|
1,265 |
1,211 |
$6K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
911 |
869 |
$6K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
165 |
158 |
$6K |
| 85379 |
|
604 |
581 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
409 |
399 |
$5K |
| 85610 |
|
1,658 |
1,571 |
$5K |
| 83880 |
|
180 |
172 |
$4K |
| 83605 |
|
641 |
603 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
53 |
42 |
$4K |
| 83735 |
|
843 |
759 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
612 |
545 |
$4K |
| 73564 |
|
181 |
169 |
$3K |
| 73610 |
|
186 |
181 |
$3K |
| 90715 |
|
261 |
257 |
$3K |
| 82805 |
|
101 |
95 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
582 |
554 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
118 |
118 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,349 |
2,112 |
$3K |
| 86850 |
|
365 |
345 |
$3K |
| 86901 |
|
581 |
523 |
$3K |
| 96376 |
|
170 |
137 |
$3K |
| 86900 |
|
581 |
523 |
$3K |
| 87077 |
|
379 |
362 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,963 |
3,649 |
$2K |
| 87186 |
|
326 |
311 |
$2K |
| 82947 |
|
763 |
640 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
63 |
62 |
$2K |
| 80076 |
|
297 |
287 |
$2K |
| 73030 |
|
146 |
140 |
$2K |
| 87631 |
|
13 |
13 |
$2K |
| 73130 |
|
168 |
159 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
95 |
89 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
94 |
88 |
$2K |
| 73630 |
|
151 |
145 |
$2K |
| 70496 |
|
12 |
12 |
$2K |
| 80051 |
|
300 |
289 |
$2K |
| 82565 |
|
336 |
322 |
$2K |
| 93000 |
|
123 |
113 |
$1K |
| 84520 |
|
330 |
316 |
$1K |
| 73110 |
|
114 |
108 |
$1K |
| T1015 |
Clinic visit/encounter, all-inclusive |
83 |
28 |
$1K |
| 51701 |
|
57 |
55 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,858 |
6,340 |
$1K |
| 90834 |
Psychotherapy, 45 minutes with patient |
141 |
99 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,673 |
2,540 |
$1K |
| 82248 |
|
181 |
173 |
$1K |
| 70486 |
|
15 |
15 |
$996.90 |
| 86140 |
|
361 |
353 |
$909.50 |
| 84443 |
Thyroid stimulating hormone (TSH) |
105 |
102 |
$810.68 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,757 |
5,310 |
$804.22 |
| 72131 |
|
14 |
14 |
$770.90 |
| 81025 |
|
217 |
204 |
$695.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,364 |
1,296 |
$681.53 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
69 |
38 |
$649.31 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
109 |
25 |
$539.94 |
| 82550 |
|
71 |
68 |
$449.12 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,494 |
1,400 |
$286.13 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,085 |
1,025 |
$279.86 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
110 |
108 |
$268.25 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
220 |
205 |
$253.12 |
| 73590 |
|
16 |
13 |
$231.86 |
| 82010 |
|
60 |
56 |
$229.25 |
| 74018 |
|
16 |
16 |
$205.91 |
| 74022 |
|
12 |
12 |
$201.98 |
| A9270 |
Non-covered item or service |
555 |
171 |
$200.66 |
| 73502 |
|
12 |
12 |
$187.81 |
| 80061 |
Lipid panel |
30 |
30 |
$171.45 |
| 73090 |
|
13 |
13 |
$163.36 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
724 |
674 |
$133.84 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
56 |
50 |
$133.01 |
| 93296 |
|
41 |
40 |
$120.95 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
631 |
520 |
$119.72 |
| 85027 |
|
41 |
30 |
$109.47 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
44 |
42 |
$106.48 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
33 |
31 |
$56.51 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
133 |
128 |
$51.86 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
110 |
103 |
$49.19 |
| 81003 |
|
18 |
18 |
$38.76 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
230 |
210 |
$35.43 |
| J2704 |
Injection, propofol, 10 mg |
173 |
169 |
$28.10 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
212 |
207 |
$15.07 |
| J2060 |
Injection, lorazepam, 2 mg |
33 |
30 |
$14.65 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
47 |
31 |
$0.00 |
| J3490 |
Unclassified drugs |
232 |
192 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
34 |
31 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
133 |
128 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
25 |
25 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
62 |
62 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
29 |
28 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
13 |
12 |
$0.00 |